Noninterruption of Warfarin Therapy is Safe and Does not Compromise Outcome in Patients Undergoing Endovenous Laser Therapy (EVLT)

Abstract

Objective: To assess the need for cessation of oral anticoagulation with warfarin for patients undergoing endovenous laser therapy (EVLT). Methods: Between September 2004 and July 2010, 518 patients underwent 770 EVLT procedures on the lower extremity, at our institution. Of these patients, 5 underwent a total of 12 separate lower extremity EVLT procedures for the treatment of symptomatic reflux without interruption of warfarin therapy. Results: No bleeding complications were observed during the procedure or in early follow-up. None of the patients developed a deep venous thrombosis. Complete ablation of the target vessel was observed in all patients on follow-up Duplex ultrasounds at 1 and 8 weeks postintervention. Conclusion: Endovenous laser therapy can be safely performed and does not compromise target vessel ablation in patients receiving oral anticoagulation warfarin therapy. Warfarin therapy should not be routinely interrupted in patients undergoing this procedure.

Keywords

anticoagulation endovenous laser therapy endovenous laser ablation warfarin venous reflux

Get full access to this article

View all access options for this article.

References

Hoggan BL , Cameron AL , Maddern GJ Systematic review of endovenous laser therapy versus surgery for the treatment of saphenous varicose veins. Ann Vasc Surg. 2009;23(2):277-287.

Van den Bos R. , Arends L. , Kockaert M. , Neumann M. , Nijsten T. Endovenous therapies of lower extremity varicosities: a meta-analysis. J Vasc Surg. 2009;49(1):230-239.

Leopardi D. , Hoggan BL , Fitridge RA , Woodruff PWH , Maddern GJ Systematic review of treatments for varicose veins. Ann Vasc Surg. 2009;23(2):264-276.

Faltas B. , Kouides PA Update on perioperative bridging in patients on chronic oral anticoagulation . Expert Rev Cardiovasc Ther. 2009;7(12):1533-1539.

Jaff MR

Chronically anticoagulated patients who need surgery: can low molecular-weight heparins really be used to ‘‘bridge’’ patients instead of intravenous unfractionated heparin?

Catheter Cardiovasc Interv. 2009;74(1)(suppl):S17-S21.

Christenson JT , Gueddi S. , Gemayel G. , Bounameaux H. Prospective randomized trial comparing endovenous laser ablation and surgery for treatment of primary great saphenous varicose veins with a 2-year follow-up. J Vasc Surg. 2010;52(5):1234-1241.

Eklof B. , Rutherford RB , Bergan JJ , et al. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg. 2004;40(6):1248-1252.

Marston WA

Evaluation of varicose veins: what do the clinical signs and symptoms reveal about the underlying disease and need for intervention?

Semin Vasc Surg. 2010;23(2):78-84.

Bernardini E. , De Rango P. , Piccioli R. , et al. Development of primary superficial venous insufficiency: the ascending theory. Observational and hemodynamic data from a 9-year experience. Ann Vasc Surg. 2010;24(6):709-720.

10.

Van Groenendael L. , Van der Vliet JA , Flinkenflogel L. , Roovers EA , Van Stekenburg SM , Reijnen MM Treatment of recurrent varicose veins of the great saphenous vein by conventional surgery and endovenous laser ablation. J Vasc Surg. 2009;50(5):1106-1113.

11.

Douketis JD , Berger PB , Dunn AS , et al. The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest . 2008;133(6)(suppl):299S-339S.

12.

Theivacumar NS , Gough MJ Influence of warfarin on the success of endovenous laser ablation (EVLA) of the great saphenous vein (GSV). Eur J Vasc Endovasc Surg. 2009;38(4):506-510.

13.

Sharifi M. , Mehdipour M. , Bay C. , Emarani F. , Sharifi J. Effect of anticoagulation on endothermal ablation of the great saphenous vein . J Vasc Surg. 2011;53(1):147-149.